Enzymotec Ltd
ENZY
ENZY was delisted on the 10th of January, 2018.
32 hedge funds and large institutions have $45.8M invested in Enzymotec Ltd in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 4 closing their positions.
6% less funds holding
Funds holding: 34 → 32 (-2)
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
20% less capital invested
Capital invested by funds: $57.2M → $45.8M (-$11.4M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gagnon Securities
New York
|
+$913K |
| 2 |
Renaissance Technologies
New York
|
+$209K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$28.4K |
| 4 |
Ohio Public Employees Retirement System (OPERS)
Columbus,
Ohio
|
+$22.9K |
| 5 |
State of Tennessee, Department of Treasury
Nashville,
Tennessee
|
+$21.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$4.99M |
| 2 |
Millennium Management
New York
|
-$1.07M |
| 3 |
GA
Gagnon Advisors
New York
|
-$394K |
| 4 |
LCM
Laurion Capital Management
New York
|
-$282K |
| 5 |
IA
Icon Advisers
Greenwood Village,
Colorado
|
-$220K |
ENZY Hedge Fund Activity: Q4 2016 in Review
32 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Enzymotec Ltd (ENZY) for Q4 2016, worth a combined $45.8M — down 20% from $57.2M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ENZY and 2 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 9 added.
The largest buyer was Gagnon Securities, adding an estimated $913K. The largest seller was Goldman Sachs, cutting an estimated $4.99M.
- 32 institutional investors held Enzymotec Ltd (ENZY) as of Q4 2016, down from 34 in Q3 2016.
- Funds reported $45.8M of Enzymotec Ltd stock for Q4 2016, down 20% quarter-over-quarter.
- 2 funds opened new Enzymotec Ltd positions in Q4 2016 and 4 closed out, a net change of -2 holders.
- The largest Enzymotec Ltd buyer in Q4 2016 was Gagnon Securities, an estimated $913K added.
- The largest Enzymotec Ltd seller in Q4 2016 was Goldman Sachs, an estimated $4.99M sold.
Based on aggregated 13F filings for Q4 2016.